High Cholesterol

References

Citations

1. Grundy SM, et al. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285(19): 2486–2497.

2. Canadian Diabetes Association (2006). Dyslipidemia in adults with diabetes. Clinical Practice Guidelines Expert Committee. Canadian Journal of Diabetes, 30(3): 230–240. Available online: http://www.medscape.com/viewarticle/546613.

3. U.S. Preventive Services Task Force, Agency for Healthcare and Research (2003). Screening for Diabetes Mellitus, Adult Type 2. Available online: http://www.ahrq.gov/clinic/uspstf/uspsdiab.htm.

4. Nissen SE, et al. (2005). Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. New England Journal of Medicine, 352(1): 29–38.

5. Ridker PM, et al. (2005). C-reactive protein levels and outcomes after statin therapy. New England Journal of Medicine, 352(1): 20–28.

6. Ridker RM, et al. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation. 107(3): 391–397.

7. Pearson TA, et al. (2003). Markers of inflammation and cardiovascular disease: American Heart Association and the Centers for Disease Control and Prevention scientific statement. Circulation, 107(3): 499–511.

8. Foster C, et al. (2004). Primary prevention. Clinical Evidence (11): 163–195.

9. Pignone M, et al. (2004). Secondary prevention of ischaemic cardiac events. Clinical Evidence (12): 193–235.

10. McPherson R, et al. (2006). Canadian Cardiovascular Society position statement—Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Canadian Journal of Cardiology, 22(11): 913–927.

11. Kraus WE, et al. (2002). Effects of the amount and intensity of exercise on plasma lipoproteins. New England Journal of Medicine, 347(19): 1483–1492.

12. Lichtenstein AH, Van Horn L (1998). Very low fat diets. Circulation, 98(9): 935–939.

13. Genest J, et al. (2003). Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: 2003 update. Canadian Medical Association Journal, 169(9). Available only online: http://www.cmaj.ca/cgi/data/169/9/921/DC1/1.

Other Works Consulted

• Brunzell JD, Failor RA (2005). Diagnosis and treatment of dyslipidemia. In DC Dale, DD Federman, eds., ACP Medicine, section 9, chap. 2. New York: WebMD.

• Kavey RW, et al. (2003). American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation, 107(11): 1562–1566.

• Maron DJ, et al. (2004). Dyslipidemia, other risk factors, and the prevention of coronary heart disease. In V Fuster et al., eds., Hurst's The Heart, 11th ed., chap. 43, pp. 1093–1122. New York: McGraw-Hill.

• Stone NJ, Blum CB (2004). Management of Lipids in Clinical Practice. Caddo, OK: Professional Communications.

Go to previous section	Go to top of page	Go to next section
Author:	Douglas Dana Ralph Poore	Last Updated: November 13, 2006
Medical Review:	Caroline S. Rhoads, MD - Internal Medicine Tom Bailey, MD - Family Medicine Neil J. Stone, MD, FACC, FACP - Internal Medicine, Cardiology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.